Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1971 Mar;33(2):290–295. doi: 10.1136/hrt.33.2.290

Haemodynamic effects of glucagon during acute myocardial infarction with left ventricular failure in man.

G Diamond, J Forrester, R Danzig, W W Parmley, H J Swan
PMCID: PMC487179  PMID: 5572666

Full text

PDF
291

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eddy J. D., O'Brien E. T., Singh S. P. Glucagon and haemodynamics of acute myocardial infarction. Br Med J. 1969 Dec 13;4(5684):663–665. doi: 10.1136/bmj.4.5684.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. FARAH A., TUTTLE R. Studies on the pharmacology of glucagon. J Pharmacol Exp Ther. 1960 May;129:49–55. [PubMed] [Google Scholar]
  3. Glick G., Parmley W. W., Wechsler A. S., Sonnenblick E. H. Glucagon. Its enhancement of cardiac performance in the cat and dog and persistence of its inotropic action despite beta-receptor blockade with propranolol. Circ Res. 1968 Jun;22(6):789–799. doi: 10.1161/01.res.22.6.789. [DOI] [PubMed] [Google Scholar]
  4. Linhart J. W., Barold S. S., Cohen L. S., Hildner F. J., Samet P. Cardiovascular effects of glucagon in man. Am J Cardiol. 1968 Nov;22(5):706–710. doi: 10.1016/0002-9149(68)90209-9. [DOI] [PubMed] [Google Scholar]
  5. Lucchesi B. R. Cardiac actions of glucagon. Circ Res. 1968 Jun;22(6):777–787. doi: 10.1161/01.res.22.6.777. [DOI] [PubMed] [Google Scholar]
  6. Mayer S. E., Namm D. H., Rice L. Effect of glucagon on cyclic 3',5'-AMP, phosphorylase activity and contractility of heart muscle of the rat. Circ Res. 1970 Feb;26(2):225–233. doi: 10.1161/01.res.26.2.225. [DOI] [PubMed] [Google Scholar]
  7. Murtagh J. G., Binnion P. F., Lal S., Hutchison K. J., Fletcher E. Haemodynamic effects of glucagon. Br Heart J. 1970 May;32(3):307–315. doi: 10.1136/hrt.32.3.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Parmley W. W., Glick G., Sonnenblick E. H. Cardiovascular effects of glucagon in man. N Engl J Med. 1968 Jul 4;279(1):12–17. doi: 10.1056/NEJM196807042790103. [DOI] [PubMed] [Google Scholar]
  9. Peel A. A., Semple T., Wang I., Lancaster W. M., Dall J. L. A CORONARY PROGNOSTIC INDEX FOR GRADING THE SEVERITY OF INFARCTION. Br Heart J. 1962 Nov;24(6):745–760. doi: 10.1136/hrt.24.6.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pullman T. N., Lavender A. R., Aho I. Direct effects of glucagon on renal hemodynamics and excretion of inorganic ions. Metabolism. 1967 Apr;16(4):358–373. doi: 10.1016/0026-0495(67)90047-9. [DOI] [PubMed] [Google Scholar]
  11. Whitsitt L. S., Lucchesi B. R. Effects of beta-receptor blockade and glucagon on the atrioventricular transmission system in the dog. Circ Res. 1968 Nov;23(5):585–595. doi: 10.1161/01.res.23.5.585. [DOI] [PubMed] [Google Scholar]
  12. Williams J. F., Jr, Childress R. H., Chip J. N., Border J. F. Hemodynamic effects of glucagon in patients with heart disease. Circulation. 1969 Jan;39(1):38–47. doi: 10.1161/01.cir.39.1.38. [DOI] [PubMed] [Google Scholar]
  13. Williams J. F., Jr Glucagon and the cardiovascular system. Ann Intern Med. 1969 Aug;71(2):419–423. doi: 10.7326/0003-4819-71-2-419. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES